UnitedHealth Group delivered a significant earnings beat for the third quarter 2026, driven by aggressive medical cost management and pricing discipline. The company’s medical care ratio improved year-over-year to 88.4%, coming in well below analyst expectations, which allowed management to raise the full-year 2026 adjusted earnings outlook to at least $20.50 per share.

Key Highlights

  • Adjusted earnings of $4.69 per share significantly exceeded the $4.12 analyst estimate, supported by a $610 million net favorable prior-period reserve development.
  • The consolidated medical care ratio (MCR) decreased to 88.4% from 89.9% in the prior year, reflecting successful benefit design changes and care delivery enhancements.
  • Operating cost ratio improved to 12.8% from 13.5% year-over-year, even as the company accelerated investments in operational technology and clinician support.
  • Optum Health revenues declined 10% to $22.9 billion due to lower value-based care patient counts in specific markets, though segment operating margins expanded significantly to 3.2%.